Nordic AMPlify 2021 [Conference] EventsBack Bay Life Science AdvisorsOctober 14, 2021biopha, medtech, Cross-border, Partnering, European BioPharma
Investment Banking Spotlight: Formation of a Next-Generation Genetic Medicine Company Investment Banking TeamOctober 14, 2021
A Conversation with SV Health Investors on Medtech Investment and Jonathan P. Gertler, BioVentures MedTech Funds [Podcast] PodcastBack Bay Life Science AdvisorsOctober 13, 2021Medtech investment, Medtech funds
Surging Investment in Remote Patient Monitoring [Podcast] PodcastBack Bay Life Science AdvisorsAugust 9, 2021Medtech, Wearables, Senors, Medtech investment
Back Bay Served as Financial Advisor in Acquisition of Novellus Therapeutics by Brooklyn ImmunoTherapeutics [Back Bay Transaction] Back Bay Transaction NewsInvestment Banking TeamJuly 20, 2021M&A, Investment Banking, Biopharma, Oncology, Cell Therapy
New Drug Pricing and Market Access [Podcast] PodcastBack Bay Life Science AdvisorsJuly 6, 2021Biotech, Market Access, Drug Pricing, FDA
Back Bay Grows International Leadership in Diagnostic Development, Clinical and Regulatory Affairs Back Bay NewsBack Bay Life Science AdvisorsJune 23, 2021Diagnostic Development, Clinical and Regulatory Affairs, BioPharma, Medtech
Antimicrobials Investment [Podcast] PodcastBack Bay Life Science AdvisorsJune 16, 2021Anti-Infectives, Anti-Microbials, Investment
Back Bay Launches New Podcast for Life Science Insiders PodcastBack Bay Life Science AdvisorsJune 7, 2021Gene Therapy, SPACS, Anti-Infectives
The Next Decade of Gene Therapy Innovation White PaperBack Bay Life Science AdvisorsMay 25, 2021Gene Therapy
Back Bay in Cell & Gene: The Next Decade In Gene Therapy Innovation, Six Critical Questions (And Answers) Back Bay in the NewsBack Bay Life Science AdvisorsMay 21, 2021Gene Therapy, Vector Technology, Biotech Investment, Rare Disease, Drug Pricing
Back Bay Life Science Advisors Appoints Berthold Hackl as Senior Advisor Back Bay NewsBack Bay Life Science AdvisorsMay 3, 2021European BioPharma, Medtech, Cross-border
STAT News: Investment in Antimicrobials Was Up in 2020, But Much Work Remains Back Bay in the NewsBack Bay Life Science AdvisorsApril 28, 2021Anti-Infectives, Vaccines, Funding, Emerging BioPharma, Commercial Development
CELL & GENE: An Analysis Of The Gene Therapy Viral Vector Landscape Back Bay Life Science AdvisorsApril 22, 2021
Creating the Optimal Term Sheet Investment Banking TeamApril 21, 2021Investment Banking, Term Sheets, IPOs
Mentoring Promising Life Science Companies from Japan’s Kansai Region Back Bay Life Science AdvisorsApril 16, 2021
Medtech Investors Take Note Investment Banking UpdateBack Bay Life Science AdvisorsMarch 8, 2021MedTech, HealthTech, Investing, Development, Investment Banking
Investment Banking Spotlight: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals Back Bay Deal TeamInvestment Banking TeamFebruary 23, 2021Biotech, M&A, Drug Development, Cannabidiol, Blockbuster, Life Sciences
The BioInnovation Institute Announces Partnership with Back Bay Life Science Advisors BlogBack Bay Life Science AdvisorsJanuary 28, 2021Emerging BioPharma, Denmark, Cross-border
PHARMACEUTICAL ONLINE: First In Line - FDA Vs. EMA Biopharma Approval Times Back Bay Life Science AdvisorsJanuary 20, 2021
